Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Alejandro C. Arroliga, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Omar A. Minai, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Omar A. Minai, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: minaio@ccf.org

Dr. Minai has indicated that he has been a consultant to Actelion Pharmaceuticals.

Drs. Gildea and Arroliga have indicated that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Alejandro C. Arroliga, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Omar A. Minai, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Omar A. Minai, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: minaio@ccf.org

Dr. Minai has indicated that he has been a consultant to Actelion Pharmaceuticals.

Drs. Gildea and Arroliga have indicated that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Alejandro C. Arroliga, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Omar A. Minai, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Omar A. Minai, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: minaio@ccf.org

Dr. Minai has indicated that he has been a consultant to Actelion Pharmaceuticals.

Drs. Gildea and Arroliga have indicated that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.